| Prev Close | 301.85 |
| Day Low/High | 303.26 / 309.77 |
| 52 Wk Low/High | 196.78 / 404.20 |
Illumina, Inc. (ILMN)
305.63
NASDAQ
| Exchange | NASDAQ |
| Shares Outstanding | 146.00B |
| Market Cap | 44.07B |
| P/E Ratio | 70.03 |
| Div & Yield | N.A. (N.A) |
Ringing 2 Bellwethers
Plus, a pair of short-term, opportunistic trading setups.
Going Their Own Ways
These two stocks have been consolidating and now appear ready to move in opposite directions.
Off the Charts
We are shifting from a multi-position, swing-trading approach to a shorter-term approach.
The 5 Dumbest Things on Wall Street: April 20
Here is this week's roundup of the dumbest actions on Wall Street.
Downgrades of Investment Banks Look Hasty
Morgan Stanley and Goldman Sachs get knocked just as their business shows signs of picking up.
Playing in Biotech -- A Primer
Biotech is changing, so here's how to invest amid the industry's new gold rush.
Illumina to Shake Off the Shorts
Labs all over the world will be drooling over its new genetic-sequencing machine.
Year-End Repairs for Your Portfolio
If you took some hard losses this year, here are some strategies for regaining ground.
Analyst Actions -- 10/7/2011
Here are today's top research calls.
The Day Ahead: Futures Lower Ahead of Jobs
The market is eagerly awaiting the September employment report, as a big divergence in either direction could affect stocks.
Not So Illuminated
It will likely be difficult for Illumina to realize its revenue-growth plans -- and the uncertainties surrounding its business should keep a lid on the stock price.
